| Revision as of 10:07, 21 November 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Saving copy of the {{drugbox}} taken from revid 461593521 of page Bethanidine for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI', 'ChEMBL', 'KEGG', 'CAS_number'). |
Latest revision as of 23:21, 6 July 2022 edit Sammi Brie (talk | contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, New page reviewers, Pending changes reviewers, Rollbackers, Template editors151,589 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper |
| Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{Drugbox |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
| ⚫ |
| verifiedrevid = 461592345 |
|
|
|
| Watchedfields = changed |
| ⚫ |
| IUPAC_name = 3-benzyl-2,1-dimethylguanidine |
|
|
⚫ |
| verifiedrevid = 461744175 |
|
⚫ |
| IUPAC_name = 3-benzyl-1,2-dimethylguanidine |
|
| image = Betanidine.png |
|
| image = Betanidine.png |
|
|
|
|
| Line 9: |
Line 11: |
|
| pregnancy_category = |
|
| pregnancy_category = |
|
| legal_status = |
|
| legal_status = |
|
| routes_of_administration = |
|
| routes_of_administration = |
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
<!--Pharmacokinetic data--> |
| Line 15: |
Line 17: |
|
| metabolism = |
|
| metabolism = |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
<!--Identifiers--> |
|
|
| IUPHAR_ligand = 7618 |
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
| CAS_number_Ref = {{cascite|changed|??}} |
|
| CAS_number = <!-- blanked - oldvalue: 55-73-2 --> |
|
| CAS_number = 55-73-2 |
|
| ATC_prefix = C02 |
|
| ATC_prefix = C02 |
|
| ATC_suffix = CC01 |
|
| ATC_suffix = CC01 |
|
|
| ChEBI_Ref = {{ebicite|correct|EBI}} |
|
| ChEBI = 37937 |
|
| ChEBI = 37937 |
|
| PubChem = 2368 |
|
| PubChem = 2368 |
| Line 28: |
Line 32: |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = W8S3YM7AUU |
|
| UNII = W8S3YM7AUU |
|
| KEGG_Ref = {{keggcite|correct|kegg}} |
|
| KEGG_Ref = {{keggcite|changed|kegg}} |
|
| KEGG = <!-- blanked - oldvalue: D01603 --> |
|
| KEGG = D01603 |
|
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
| ChEMBL = <!-- blanked - oldvalue: 1201260 --> |
|
| ChEMBL = 1201260 |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 2278 |
|
| ChemSpiderID = 2278 |
|
| SMILES = N(=C(/NCc1ccccc1)NC)\C |
|
| smiles = N(=C(/NCc1ccccc1)NC)\C |
|
| InChI = 1/C10H15N3/c1-11-10(12-2)13-8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3,(H2,11,12,13) |
|
|
| InChIKey = NIVZHWNOUVJHKV-UHFFFAOYAG |
|
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C10H15N3/c1-11-10(12-2)13-8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3,(H2,11,12,13) |
|
| StdInChI = 1S/C10H15N3/c1-11-10(12-2)13-8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3,(H2,11,12,13) |
| Line 44: |
Line 46: |
|
<!--Chemical data--> |
|
<!--Chemical data--> |
|
| C=10 | H=15 | N=3 |
|
| C=10 | H=15 | N=3 |
|
| molecular_weight = 177.25 g/mol |
|
|
}} |
|
}} |
|
|
|
|
|
'''Bethanidine''' (or '''betanidine''') is a ] drug.<ref>{{cite journal | vauthors = Prichard BN, Johnston AW, Hill ID, Rosenheim ML | title = Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison | journal = British Medical Journal | volume = 1 | issue = 5585 | pages = 135–44 | date = January 1968 | pmid = 20791420 | pmc = 1984601 | doi = 10.1136/bmj.1.5585.135 }}</ref> |
|
|
|
|
|
== See also == |
|
|
* ] |
|
|
|
|
|
== References == |
|
|
{{Reflist}} |
|
|
|
|
|
{{Antihypertensives and diuretics}} |
|
|
|
|
|
] |
|
|
] |
|
|
|
|
|
{{antihypertensive-stub}} |